Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
GCH1 encodes a member of the GTP cyclohydrolase family.
Showing 10 out of 85 products:
Human Monoclonal GCH1 Primary Antibody for IHC (p), IP - ABIN561018
Widder, Chen, Li, Dikalov, Thöny, Hatakeyama, Harrison: Regulation of tetrahydrobiopterin biosynthesis by shear stress. in Circulation research 2007
Show all 11 Pubmed References
Human Polyclonal GCH1 Primary Antibody for ELISA, IHC - ABIN1584545
Meng, Liang, Li, Chen, Liu, Li: Changes of GTP cyclohydrolase I and neuronal apoptosis in rat spinal dorsal cord induced by sciatic nerve injury. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2014
Show all 2 Pubmed References
Human Polyclonal GCH1 Primary Antibody for ELISA, WB - ABIN451682
Tegeder, Costigan, Griffin, Abele, Belfer, Schmidt, Ehnert, Nejim, Marian, Scholz, Wu, Allchorne, Diatchenko, Binshtok, Goldman, Adolph, Sama, Atlas, Carlezon, Parsegian, Lötsch, Fillingim, Maixner et al.: GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. ... in Nature medicine 2006
Our results suggest that rs329648 is associated with risk of developing PD in the Han Chinese population. Our findings should be verified in further studies, and they highlight the need for functional studies of MIR4697.
Association analysis indicated that the Tibetan version of GCH1 was significantly associated with multiple physiological traits in Tibetans, including blood nitric oxide concentration, blood oxygen saturation, and hemoglobin concentration.
This study indicates that mutations in GCH1 are rare in late-onset Parkinson disease.
This study shown GCH1 genetic variants for Parkinson's disease are associated with the risk of incident Parkinson's disease in the general population and with impairment in daily functioning in individuals without clinical parkinsonism.
GCH1 variants affect early PD risk through altered dopamine uptake, and aging alters how genetic factors contribute to disease development.
This study demonstrated that whole-exome sequencing show reveled GCH1 mutation with early-onset generalized dystonia.
Deletion of GCH1 likely contributes to dopa-responsive dystonia.
High GCH1 expression is associated with esophageal squamous cell carcinoma.
Dopa-responsive dystonia phenotype may have heterogeneous genetic background and may be caused by point mutations or rearrangements in the GCH1 gene as well as in the PARK2 (show PARK2 Antibodies) gene.
This study found that rs11158026 (GCH1) is associated with Parkinson disease in Iran population.
GCH1-induced cardioprotection against DCM mainly involves the tetrahydrobiopterin/nNOS (show NOS1 Antibodies)/sarcoplasmic reticulum Ca2 (show CA2 Antibodies)+ handling proteins signaling pathway and depression of p38 (show CRK Antibodies) Mitogen-Activated Protein Kinases in Diabetes Mellitus, Type 1.
Cardiomyocyte-specific overexpression of GTP cyclohydrolase I (mGCH) increases BH4 several-fold in the heart.
gene expression analysis after iNOS (show NOS2 Antibodies) induction identified 78 genes that were altered between wild-type and Gch1(fl/fl (show FLT3LG Antibodies))Tie2cre macrophages
Data indicate that global deficiency in GTP cyclohydrolase I (Gch1) is embryonically lethal between E11.5 and E13.5.
There is a cell-autonomous role of endothelial GTP cyclohydrolase 1 and tetrahydrobiopterin in blood pressure regulation.
Inhibition of GCH1 prevented the Escherichia coli K1 induced expression of CD64 (show FCGR1A Antibodies) in macrophages in vitro and the development of bacteremia in a newborn mouse model of meningitis.
The GTPCH I/Tetreahydrobiopterin pathway is critical to preserve endothelial progenitor cells quantity, function, and regenerative capacity during wound healing in type 1 diabetic mice.
maintenance of endothelial GTPCH I expression and the resulting improvement in BH4 biosynthesis ameliorate diabetic nephropathy
The involvement of the GCH1 gene in pain models using the hyperphenylalaninemia 1 (hph-1 (show EGLN2 Antibodies)) mouse, is reported.
GTPCH1 non-covalently interacts with polyubiquitin via an ubiquitin-binding domain.
This gene encodes a member of the GTP cyclohydrolase family. The encoded protein is the first and rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, catalyzing the conversion of GTP into 7,8-dihydroneopterin triphosphate. BH4 is an essential cofactor required by aromatic amino acid hydroxylases as well as nitric oxide synthases. Mutations in this gene are associated with malignant hyperphenylalaninemia and dopa-responsive dystonia. Several alternatively spliced transcript variants encoding different isoforms have been described\; however, not all variants give rise to a functional enzyme.
GTP cyclohydrolase I
, dystonia 14
, guanosine 5'-triphosphate cyclohydrolase I
, GTP cyclohydrolase 1 (dopa-responsive dystonia)
, GTP cyclohydrolase 1
, GTP cyclohydrolase I (form A; N-terminus)